Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06407336
Other study ID # MSRSW/Batch-Fall22/702
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 1, 2023
Est. completion date September 1, 2024

Study information

Verified date May 2024
Source Superior University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

the concept of spherical equivalent plays a pivotal role in simplifying the prescription and enhancing communication between eye care professionals and patients. The spherical equivalent is a calculated value that condenses the spherical and cylindrical components into a single power.


Description:

Mathematically, it is determined by adding half of the cylindrical power to the spherical power (SE = Sphere + (Cylinder/2)). This calculated value serves as a convenient representation of the overall refractive error, aiding in a more straightforward understanding of the prescription. Understanding their individual and collective impact on contrast sensitivity opens up new avenues for refining corrective interventions and enhancing the overall quality of vision. This article aims to demystify the intricate relationship between spherical equivalent and cylindrical correction, and their collective impact on contrast sensitivity.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 68
Est. completion date September 1, 2024
Est. primary completion date March 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Patients within 18 to 35 years will be included. - Both genders will be included. - Patients having astigmatism will be included. - Patients having 6/6 corrected vision will be included. - Eyes having no other ocular pathology will be included. - Patients having no history of ocular surgery or corneal scar will be included. Exclusion Criteria: - i. Eyes having any ocular pathology will be excluded. - Patients with corneal suture will be excluded. - Those using contact lenses instead of spectacles for vision correction will be excluded. - Participants with a history of eye surgery within the past year will be excluded.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Contrast sensitivity
Contrast sensitivity will be assessed by using two different techniques of refraction on is Cylinderical lens and other is Spherical equivalent
Other:
Refraction
Refraction will be performed and contrast sensitivity will be assessed to assess patient comfort level and compliance.

Locations

Country Name City State
Pakistan Sehat Medical Complex Hanjarwal Lahore Punjab

Sponsors (1)

Lead Sponsor Collaborator
Superior University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Contrast sensitivity The ability to perceive sharp and clear outlines of very small objects. It is also defined as the ability to identify minute differences in the shadings and patterns. CS helps detect objects without a clear outline and distinguish them from their background contrast 12 Months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03166072 - Low-vision Rehabilitation Program for Low-vision Patients and Care Givers N/A
Recruiting NCT06107881 - Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision N/A
Terminated NCT04276610 - Words on the Brain: Can Reading Rehabilitation for Age-Related Vision Impairment Improve Cognitive Functioning? N/A
Recruiting NCT04892316 - Using Machine Learning to Adapt Visual Aids for Patients With Low Vision
Recruiting NCT04919837 - The Efficacy of an Artificial Intelligence Platform to Adapt Visual Aids for Patients With Low Vision: a Randomised Controlled Trial N/A
Completed NCT04483882 - Tactile Low Vision Labeling of Ophthalmic Drops N/A